Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
E. Nena, P. Steiropoulos, A. Tzouvelekis, N. Papanas, G. Zacharis, K. Archontogeorgis, M. Kouratzi, A. Koulelidis, P. Boglou, M. Froudarakis, D. Bouros (Alexandroupolis, Greece). Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment. Eur Respir J 2012; 40: Suppl. 56, 3808

Member's Comments

No comment yet.

Related content which might interest you: Insulin-like growth factor binding protein-3 induction by transforming growth factor-β1 mediates differentiation of a myofibroblast phenotype in human lung fibroblasts Source: Eur Respir J 2003; 22: Suppl. 45, 7s Year: 2003 Autocrine expression of mechano and insulin-like 1 growth factors (MGF & IGF-1) in the diaphragm of severe COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 573s Year: 2003 Overexpression of fibroblast growth factor and down-regulation of platelet-derived growth factor correlate with advanced-stage lung fibrosis Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005 Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a prognostic factor of survival in patients with lung adenocarcinoma Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Increased expression of insulin-like growth factor-binding protein-7 (IGFBP7) in fibroblasts from patients with emphysema Source: Eur Respir J 2004; 24: Suppl. 48, 95s Year: 2004 Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 459s Year: 2005 Serum levels of vascular endothelial growth factor in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004 Diaphragmatic angiogenic growth factor mRNA responses to increased ventilation caused by hypoxia and hypercapnia Source: Eur Respir J 2001; 17: 681-687 Year: 2001 Insulin-like growth factor-I (IGF-I) in COPD exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 435s Year: 2003 Insulin-like growth factor-I (IGF-I) in COPD exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002 Circulating vascular endothelial growth factor and osteoporosis in patients with COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Platelet-derived growth factor levels in sputum of patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002 Serum levels of vascular endothelial growth factor in patients with active pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 341s Year: 2006 Influence of tobacco-smoking on serum level of transforming growth factor (TGF) beta 1 in COPD patients Source: International Congress 2017 – COPD biomarkers Year: 2017 Levels of plasma tumour necrosis factor and soluble tumour necrosis factor receptor in patients with COPD and its relation to glucocorticoid receptor levels Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Fibroblast growth factor 23 and Klotho contribute to airway inflammation Source: Eur Respir J, 52 (1) 1800236; 10.1183/13993003.00236-2018 Year: 2018 Low plasma stem cell factor combined with high transforming growth factor-a identifies high-risk patients in pulmonary arterial hypertension Source: ERJ Open Res, 4 (4) 00035-2018; 10.1183/23120541.00035-2018 Year: 2018